Novanta/$NOVT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Novanta
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Ticker
$NOVT
Sector
Primary listing
Industry
Electronic Equipment, Instruments and Components
Headquarters
Employees
3,000
ISIN
CA67000B1040
Website
Novanta Metrics
BasicAdvanced
$4.4B
63.06
$1.95
1.51
-
Price and volume
Market cap
$4.4B
Beta
1.51
52-week high
$187.00
52-week low
$98.76
Average daily volume
241K
Financial strength
Current ratio
2.56
Quick ratio
1.594
Long term debt to equity
55.466
Total debt to equity
55.709
Interest coverage (TTM)
4.45%
Profitability
EBITDA (TTM)
184.77
Gross margin (TTM)
45.00%
Net profit margin (TTM)
7.42%
Operating margin (TTM)
13.51%
Effective tax rate (TTM)
20.27%
Revenue per employee (TTM)
$320,000
Management effectiveness
Return on assets (TTM)
5.75%
Return on equity (TTM)
9.73%
Valuation
Price to earnings (TTM)
63.056
Price to revenue (TTM)
4.648
Price to book
5.74
Price to tangible book (TTM)
1,485.44
Price to free cash flow (TTM)
31.08
Free cash flow yield (TTM)
3.22%
Free cash flow per share (TTM)
395.63%
Growth
Revenue change (TTM)
6.52%
Earnings per share change (TTM)
1.57%
3-year revenue growth (CAGR)
8.34%
10-year revenue growth (CAGR)
9.61%
3-year earnings per share growth (CAGR)
6.38%
10-year earnings per share growth (CAGR)
11.91%
What the Analysts think about Novanta
Analyst ratings (Buy, Hold, Sell) for Novanta stock.
Bulls say / Bears say
Novanta reported a 12.5% year-over-year increase in Q4 2024 revenue, reaching $238.1 million, indicating strong growth momentum. (nasdaq.com)
The company's adjusted EBITDA for the full year 2024 rose by 7% to $210 million, reflecting improved operational efficiency. (tradingview.com)
Novanta's strategic initiatives included the launch of multiple new products in 2024, expected to ramp up in 2025, positioning the company for future growth. (tradingview.com)
Novanta's CFO sold over $770,000 worth of company stock in September 2024, which could be perceived negatively by investors. (investing.com)
Analyst Robert W. Baird downgraded Novanta's price target from $169.00 to $160.00 in March 2025, indicating potential concerns about the company's valuation. (defenseworld.net)
Novanta's stock price has experienced volatility, with a 52-week range between $98.76 and $187.12, which may concern risk-averse investors. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.
Novanta Financial Performance
Revenues and expenses
Novanta Earnings Performance
Company profitability
Novanta News
AllArticlesVideos
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
Business Wire·2 weeks ago
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
Business Wire·1 month ago
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novanta stock?
Novanta (NOVT) has a market cap of $4.4B as of July 21, 2025.
What is the P/E ratio for Novanta stock?
The price to earnings (P/E) ratio for Novanta (NOVT) stock is 63.06 as of July 21, 2025.
Does Novanta stock pay dividends?
No, Novanta (NOVT) stock does not pay dividends to its shareholders as of July 21, 2025.
When is the next Novanta dividend payment date?
Novanta (NOVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Novanta?
Novanta (NOVT) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.